Nicholas lain James Paton

Paton Nicholas lain James

Appointment(s)
  • Professor, Department of Medicine
  • Senior Consultant, Division of Infectious Disease, University Medicine Cluster, National University Health System
Administrative Appointment(s)
  • Research Director, University Medicine Cluster, National University Health System
  • Director, SPRINT-TB Programme, National University Health System
  • Lead, Tuberculosis Summit Research Programme, National University Health System
Academic Qualifications
  • BA, University of Cambridge, United Kingdom
  • MBBChir, University of Cambridge, United Kingdom
  • MA, University of Cambridge, United Kingdom
  • MD, University of Cambridge, United Kingdom
  • MSc (Epidemiology), University of Cambridge, United Kingdom
Research Interest(s)
  • HIV
  • Tuberculosis
  • Clinical Trials
  • Treatment
Recent Publications
  • 1. Dunn, D. T., Stöhr, W., Arenas-Pinto, A., Tostevin, A., Mbisa, J. L., & Paton, N. I. (2018). Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy. Journal of Clinical Virology, 101, 63-65. doi:10.1016/j.jcv.2018.02.003
  • 2. Hakim, J. G., Thompson, J., Kityo, C., Hoppe, A., Kambugu, A., van Oosterhout, J. J., . . . Kemigisa, M. (2018). Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. The Lancet Infectious Diseases, 18(1), 47-57. doi:10.1016/S1473-3099(17)30630-8
  • 3. Hoppe, A., Giuliano, M., Lugemwa, A., Thompson, J. A., Floridia, M., Walker, A. S., . . . EARNEST Trial Team. (2018). HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.. Antivir Ther, 23(2), 191-195. doi:10.3851/IMP3200
  • 4. Parmar, M. K. B., Sydes, M. R., Cafferty, F. H., Choodari-Oskooei, B., Langley, R. E., Brown, L., . . . Royston, P. J. (2017). Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols. Clinical Trials, 14(5), 451-461. doi:10.1177/1740774517725697
  • 5. Molton, J. S., Singh, S., Chen, L. J., & Paton, N. I. (2017). International tuberculosis research collaborations within Asia. BMC Research Notes, 10(1). doi:10.1186/s13104-017-2769-4